Journal article
In cancer-associated thrombosis, DOACs reduce VTE and increase clinically relevant nonmajor bleeding vs. LMWH at 3 to 12 mo.
Abstract
CLINICAL IMPACT RATINGS: GIM/FP/GP: [Formula: see text] Oncology: [Formula: see text] Hematology: [Formula: see text].
Authors
Godoy A; Douketis JD
Journal
Annals of Internal Medicine, , ,
Publisher
American College of Physicians
Publication Date
November 4, 2025
DOI
10.7326/annals-25-04088-jc
ISSN
1056-8751